COVID Vaccine Mistrust Levels Aren't Budging, Study Finds
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Nov. 6, 2024 -- More than a third of Americans continue to express mistrust in the science behind COVID vaccines, a new study finds.
This level of mistrust has remained relatively consistent, expressed by 36% of people in 2021, 33% in 2022 and 36% in 2023.
People who lost a family member or close friend to COVID were significantly more likely to trust vaccine science and accept vaccination, results showed.
For example, those who experienced a loss within the past year were nearly four times more likely to trust vaccine experts, compared to those who didn’t lose someone, researchers found.
"Our findings underscore the critical role of trust in science during public health crises,” said lead researcher Trenton White, a postdoctoral fellow with the Barcelona Institute for Global Health. “The fact that personal experiences of loss due to COVID-19 was associated with trust levels highlights the need for public health communications to be sensitive to the emotional impact of the pandemic."
Overall, vaccine acceptance tended to be higher in men, people with college degrees and higher-income families.
In the future, public health officials should consider the diverse backgrounds of the U.S. population and cater messages to effectively build and maintain trust in science, the researchers said.
“This research provides valuable insights for policymakers and health communicators as they continue to navigate the ongoing challenge of global vaccine hesitancy,” senior researcher Ayman El-Mohandes, dean of the CUNY Graduate School of Public Health and Health Policy, said in a CUNY news release.
The new study was published Nov. 2 in the journal Vaccine: X.
Sources
- CUNY Graduate School of Public Health and Health Policy, news release, Nov. 4, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
MONDAY, July 21, 2025 -- The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the...
Few Babies Getting RSV Antibody Shot, Beyfortus, Study Says
THURSDAY, July 17, 2025 — A new antibody shot that protects babies against RSV infection could be struggling to gain traction, researchers report. Only about a third (35%)...
WHO, UNICEF Say More Than 14 Million Infants Worldwide Remain Unvaccinated
WEDNESDAY, July 16, 2025 -- Data released this week by the World Health Organization and UNICEF indicate modest gains in childhood vaccination rates, but globally, more than 14...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.